Literature DB >> 2909370

Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures.

T L McCarthy1, M Centrella, E Canalis.   

Abstract

Insulin-like growth factors I and II (IGF-I and -II) are polypeptides secreted by skeletal cells and are considered regulators of bone formation. IGF-I and -II were studied for their effects on collagen synthesis and degradation in cultures of intact fetal rat calvariae and on type I collagen transcript levels in osteoblast-enriched (Ob) cells from fetal rat parietal bone. IGF-I and -II increased [3H]proline incorporation into type I collagen independently of their effect on cell replication. IGF-I and -II also decreased collagen degradation in calvarial cultures. Both factors had similar actions, although IGF-I stimulated collagen synthesis at 10 nM, and IGF-II at 30 nM. In Ob cells, IGF-I and -II also increased [3H]proline incorporation into type I collagen, but the effect was seen at 100 nM, and neither factor decreased collagen degradation. Slot blot analysis of IGF-I- and IGF-II-treated cells, using a rat type I collagen cDNA probe, revealed an increase in type I collagen transcripts. In conclusion, IGF-I and -II increase bone collagen synthesis and decrease collagen degradation in cultures of intact calvariae; the effect on collagen synthesis correlates with an increase in transcript levels in Ob cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909370     DOI: 10.1210/endo-124-1-301

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  44 in total

Review 1.  Implications of exercise-induced adipo-myokines in bone metabolism.

Authors:  Giovanni Lombardi; Fabian Sanchis-Gomar; Silvia Perego; Veronica Sansoni; Giuseppe Banfi
Journal:  Endocrine       Date:  2015-12-30       Impact factor: 3.633

Review 2.  Growth factors and the skeletal system.

Authors:  E Canalis; T L McCarthy; M Centrella
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

3.  Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cells.

Authors:  H L Merriman; D La Tour; T A Linkhart; S Mohan; D J Baylink; D D Strong
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

4.  The regulation of L-proline transport by insulin-like growth factor-I in human osteoblast-like SaOS-2 cells.

Authors:  Y Kudo; M Iwashita; T Iguchi; Y Takeda
Journal:  Pflugers Arch       Date:  1996-07       Impact factor: 3.657

5.  Effects of rhIGF-I administration on bone turnover during short-term fasting.

Authors:  S K Grinspoon; H B Baum; S Peterson; A Klibanski
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

6.  IGF-I regulates tight-junction protein claudin-1 during differentiation of osteoblast-like MC3T3-E1 cells via a MAP-kinase pathway.

Authors:  Naoko Hatakeyama; Takashi Kojima; Kousuke Iba; Masaki Murata; Mia M Thi; David C Spray; Makoto Osanai; Hideki Chiba; Sumio Ishiai; Toshihiko Yamashita; Norimasa Sawada
Journal:  Cell Tissue Res       Date:  2008-10-15       Impact factor: 5.249

7.  Insulinlike growth factor gene expression in human fracture callus.

Authors:  J G Andrew; J Hoyland; A J Freemont; D Marsh
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

8.  Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.

Authors:  F Sato; Y Ouchi; A Masuyama; T Nakamura; T Hosoi; Y Okamoto; N Sasaki; M Shiraki; H Orimo
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

9.  Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.

Authors:  Inga-Lill Engvall; Birgitta Tengstrand; Kerstin Brismar; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2010-10-21       Impact factor: 5.156

10.  Osteoporosis syndrome in thalassaemia major: an overview.

Authors:  Meropi Toumba; Nicos Skordis
Journal:  J Osteoporos       Date:  2010-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.